semaglutide cardiac effects and the Heart: Focus on Their Love–Hate Relationship A new indication for Wegovy

doi: 10.3390/ijerph19010137 32 HiluyJCNazarBPGonalvesWSCoutinhoWAppolinarioJC

Use the calculators number as a starting target, not a fixed rule

The PROactive 294 trial showed that pioglitazone, compared with a placebo, reduced the risk of composite outcomes (all-cause mortality, nonfatal MI and stroke) by 16% in diabetic patients with established ASCVD

It's crucial to follow your management plan to avoid unnecessary complications and to acheive optimal results

Nikoli R, Krsti N, Jovanovi J, Koci G, Cvetkovi TP, Radosavljevi-Stevanovi N

Quantitative data are expressed as the mean and error bars represent the standard error of the mean (SEM) unless otherwise indicated